医療用生物学的ペンチレンジアミンのグローバル市場展望 2023年-2029年：純度98.5%-99%、純度≧99%

◆英語タイトル：Biological Pentylenediamine for Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC01254）

◆商品コード：MMG23DC01254
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：115
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の医療用生物学的ペンチレンジアミン市場規模と予測を収録しています。・世界の医療用生物学的ペンチレンジアミン市場：売上、2018年-2023年、2024年-2029年
・世界の医療用生物学的ペンチレンジアミン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用生物学的ペンチレンジアミン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度98.5%-99%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医療用生物学的ペンチレンジアミンのグローバル主要企業は、Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医療用生物学的ペンチレンジアミンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医療用生物学的ペンチレンジアミン市場：タイプ別、2018年-2023年、2024年-2029年
世界の医療用生物学的ペンチレンジアミン市場：タイプ別市場シェア、2022年
・純度98.5%-99%、純度≧99%

世界の医療用生物学的ペンチレンジアミン市場：用途別、2018年-2023年、2024年-2029年
世界の医療用生物学的ペンチレンジアミン市場：用途別市場シェア、2022年
・製薬、医療研究、その他

世界の医療用生物学的ペンチレンジアミン市場：地域・国別、2018年-2023年、2024年-2029年
世界の医療用生物学的ペンチレンジアミン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医療用生物学的ペンチレンジアミンのグローバル売上、2018年-2023年
・主要企業における医療用生物学的ペンチレンジアミンのグローバル売上シェア、2022年
・主要企業における医療用生物学的ペンチレンジアミンのグローバル販売量、2018年-2023年
・主要企業における医療用生物学的ペンチレンジアミンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologies

*************************************************************

・調査・分析レポートの概要
医療用生物学的ペンチレンジアミン市場の定義
市場セグメント
世界の医療用生物学的ペンチレンジアミン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用生物学的ペンチレンジアミン市場規模
世界の医療用生物学的ペンチレンジアミン市場規模：2022年 VS 2029年
世界の医療用生物学的ペンチレンジアミン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用生物学的ペンチレンジアミンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用生物学的ペンチレンジアミン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：純度98.5%-99%、純度≧99%
医療用生物学的ペンチレンジアミンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：製薬、医療研究、その他
医療用生物学的ペンチレンジアミンの用途別グローバル売上・予測

・地域別市場分析
地域別医療用生物学的ペンチレンジアミン市場規模 2022年と2029年
地域別医療用生物学的ペンチレンジアミン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologies
...

This research report provides a comprehensive analysis of the Biological Pentylenediamine for Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biological Pentylenediamine for Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biological Pentylenediamine for Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Biological Pentylenediamine for Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biological Pentylenediamine for Medicine market presents opportunities for various stakeholders, including Pharmaceutical Industry, Medical Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biological Pentylenediamine for Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biological Pentylenediamine for Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Biological Pentylenediamine for Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biological Pentylenediamine for Medicine market.
Market Overview: The report provides a comprehensive overview of the Biological Pentylenediamine for Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Purity 98.5%-99%, Purity ≥99%), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biological Pentylenediamine for Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biological Pentylenediamine for Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biological Pentylenediamine for Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biological Pentylenediamine for Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biological Pentylenediamine for Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biological Pentylenediamine for Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biological Pentylenediamine for Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biological Pentylenediamine for Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biological Pentylenediamine for Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Purity 98.5%-99%
Purity ≥99%
Market segment by Application
Pharmaceutical Industry
Medical Research
Others
Global Biological Pentylenediamine for Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Cathay Biotech
Aphena Pharma Solutions
Bio-Tech Pharmacal
Goodwin Biotechnology
Xenon Pharmaceuticals
Nektar Therapeutics
Midas Pharmaceuticals
Kedrion Biopharma
Xcelthera
Anichem
ALC Bio Innovations
ACADIA Pharmaceuticals
AbbVie
Ology Bioservices
QMI – Quality Management
Biomiga
Molecular Targeting Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Pentylenediamine for Medicine, market overview.
Chapter 2: Global Biological Pentylenediamine for Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Pentylenediamine for Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Pentylenediamine for Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Pentylenediamine for Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biological Pentylenediamine for Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Pentylenediamine for Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Pentylenediamine for Medicine Overall Market Size
2.1 Global Biological Pentylenediamine for Medicine Market Size: 2022 VS 2029
2.2 Global Biological Pentylenediamine for Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biological Pentylenediamine for Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Biological Pentylenediamine for Medicine Players in Global Market
3.2 Top Global Biological Pentylenediamine for Medicine Companies Ranked by Revenue
3.3 Global Biological Pentylenediamine for Medicine Revenue by Companies
3.4 Global Biological Pentylenediamine for Medicine Sales by Companies
3.5 Global Biological Pentylenediamine for Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biological Pentylenediamine for Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biological Pentylenediamine for Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biological Pentylenediamine for Medicine Players in Global Market
3.8.1 List of Global Tier 1 Biological Pentylenediamine for Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Biological Pentylenediamine for Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biological Pentylenediamine for Medicine Market Size Markets, 2022 & 2029
4.1.2 Purity 98.5%-99%
4.1.3 Purity ≥99%
4.2 By Type – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
4.2.1 By Type – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
4.2.2 By Type – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
4.2.3 By Type – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Biological Pentylenediamine for Medicine Sales & Forecasts
4.3.1 By Type – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
4.3.2 By Type – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
4.3.3 By Type – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Biological Pentylenediamine for Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biological Pentylenediamine for Medicine Market Size, 2022 & 2029
5.1.2 Pharmaceutical Industry
5.1.3 Medical Research
5.1.4 Others
5.2 By Application – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
5.2.1 By Application – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
5.2.2 By Application – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
5.2.3 By Application – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Biological Pentylenediamine for Medicine Sales & Forecasts
5.3.1 By Application – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
5.3.2 By Application – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
5.3.3 By Application – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Biological Pentylenediamine for Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biological Pentylenediamine for Medicine Market Size, 2022 & 2029
6.2 By Region – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
6.2.1 By Region – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
6.2.2 By Region – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
6.2.3 By Region – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Biological Pentylenediamine for Medicine Sales & Forecasts
6.3.1 By Region – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
6.3.2 By Region – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
6.3.3 By Region – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.4.2 By Country – North America Biological Pentylenediamine for Medicine Sales, 2018-2029
6.4.3 US Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.4.4 Canada Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.4.5 Mexico Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Biological Pentylenediamine for Medicine Sales, 2018-2029
6.5.3 Germany Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.4 France Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.5 U.K. Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.6 Italy Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.7 Russia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.9 Benelux Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Biological Pentylenediamine for Medicine Sales, 2018-2029
6.6.3 China Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.4 Japan Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.5 South Korea Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.7 India Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.7.2 By Country – South America Biological Pentylenediamine for Medicine Sales, 2018-2029
6.7.3 Brazil Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.7.4 Argentina Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biological Pentylenediamine for Medicine Sales, 2018-2029
6.8.3 Turkey Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.4 Israel Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.6 UAE Biological Pentylenediamine for Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cathay Biotech
7.1.1 Cathay Biotech Company Summary
7.1.2 Cathay Biotech Business Overview
7.1.3 Cathay Biotech Biological Pentylenediamine for Medicine Major Product Offerings
7.1.4 Cathay Biotech Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Cathay Biotech Key News & Latest Developments
7.2 Aphena Pharma Solutions
7.2.1 Aphena Pharma Solutions Company Summary
7.2.2 Aphena Pharma Solutions Business Overview
7.2.3 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Major Product Offerings
7.2.4 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Aphena Pharma Solutions Key News & Latest Developments
7.3 Bio-Tech Pharmacal
7.3.1 Bio-Tech Pharmacal Company Summary
7.3.2 Bio-Tech Pharmacal Business Overview
7.3.3 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Major Product Offerings
7.3.4 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Bio-Tech Pharmacal Key News & Latest Developments
7.4 Goodwin Biotechnology
7.4.1 Goodwin Biotechnology Company Summary
7.4.2 Goodwin Biotechnology Business Overview
7.4.3 Goodwin Biotechnology Biological Pentylenediamine for Medicine Major Product Offerings
7.4.4 Goodwin Biotechnology Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Goodwin Biotechnology Key News & Latest Developments
7.5 Xenon Pharmaceuticals
7.5.1 Xenon Pharmaceuticals Company Summary
7.5.2 Xenon Pharmaceuticals Business Overview
7.5.3 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.5.4 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Xenon Pharmaceuticals Key News & Latest Developments
7.6 Nektar Therapeutics
7.6.1 Nektar Therapeutics Company Summary
7.6.2 Nektar Therapeutics Business Overview
7.6.3 Nektar Therapeutics Biological Pentylenediamine for Medicine Major Product Offerings
7.6.4 Nektar Therapeutics Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.6.5 Nektar Therapeutics Key News & Latest Developments
7.7 Midas Pharmaceuticals
7.7.1 Midas Pharmaceuticals Company Summary
7.7.2 Midas Pharmaceuticals Business Overview
7.7.3 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.7.4 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.7.5 Midas Pharmaceuticals Key News & Latest Developments
7.8 Kedrion Biopharma
7.8.1 Kedrion Biopharma Company Summary
7.8.2 Kedrion Biopharma Business Overview
7.8.3 Kedrion Biopharma Biological Pentylenediamine for Medicine Major Product Offerings
7.8.4 Kedrion Biopharma Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.8.5 Kedrion Biopharma Key News & Latest Developments
7.9 Xcelthera
7.9.1 Xcelthera Company Summary
7.9.2 Xcelthera Business Overview
7.9.3 Xcelthera Biological Pentylenediamine for Medicine Major Product Offerings
7.9.4 Xcelthera Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.9.5 Xcelthera Key News & Latest Developments
7.10 Anichem
7.10.1 Anichem Company Summary
7.10.2 Anichem Business Overview
7.10.3 Anichem Biological Pentylenediamine for Medicine Major Product Offerings
7.10.4 Anichem Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.10.5 Anichem Key News & Latest Developments
7.11 ALC Bio Innovations
7.11.1 ALC Bio Innovations Company Summary
7.11.2 ALC Bio Innovations Business Overview
7.11.3 ALC Bio Innovations Biological Pentylenediamine for Medicine Major Product Offerings
7.11.4 ALC Bio Innovations Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.11.5 ALC Bio Innovations Key News & Latest Developments
7.12 ACADIA Pharmaceuticals
7.12.1 ACADIA Pharmaceuticals Company Summary
7.12.2 ACADIA Pharmaceuticals Business Overview
7.12.3 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.12.4 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.12.5 ACADIA Pharmaceuticals Key News & Latest Developments
7.13 AbbVie
7.13.1 AbbVie Company Summary
7.13.2 AbbVie Business Overview
7.13.3 AbbVie Biological Pentylenediamine for Medicine Major Product Offerings
7.13.4 AbbVie Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.13.5 AbbVie Key News & Latest Developments
7.14 Ology Bioservices
7.14.1 Ology Bioservices Company Summary
7.14.2 Ology Bioservices Business Overview
7.14.3 Ology Bioservices Biological Pentylenediamine for Medicine Major Product Offerings
7.14.4 Ology Bioservices Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.14.5 Ology Bioservices Key News & Latest Developments
7.15 QMI – Quality Management
7.15.1 QMI – Quality Management Company Summary
7.15.2 QMI – Quality Management Business Overview
7.15.3 QMI – Quality Management Biological Pentylenediamine for Medicine Major Product Offerings
7.15.4 QMI – Quality Management Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.15.5 QMI – Quality Management Key News & Latest Developments
7.16 Biomiga
7.16.1 Biomiga Company Summary
7.16.2 Biomiga Business Overview
7.16.3 Biomiga Biological Pentylenediamine for Medicine Major Product Offerings
7.16.4 Biomiga Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.16.5 Biomiga Key News & Latest Developments
7.17 Molecular Targeting Technologies
7.17.1 Molecular Targeting Technologies Company Summary
7.17.2 Molecular Targeting Technologies Business Overview
7.17.3 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Major Product Offerings
7.17.4 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.17.5 Molecular Targeting Technologies Key News & Latest Developments
8 Global Biological Pentylenediamine for Medicine Production Capacity, Analysis
8.1 Global Biological Pentylenediamine for Medicine Production Capacity, 2018-2029
8.2 Biological Pentylenediamine for Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Biological Pentylenediamine for Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biological Pentylenediamine for Medicine Supply Chain Analysis
10.1 Biological Pentylenediamine for Medicine Industry Value Chain
10.2 Biological Pentylenediamine for Medicine Upstream Market
10.3 Biological Pentylenediamine for Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biological Pentylenediamine for Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用生物学的ペンチレンジアミンのグローバル市場展望 2023年-2029年：純度98.5%-99%、純度≧99%(Biological Pentylenediamine for Medicine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医療用生物学的ペンチレンジアミンのグローバル市場展望 2023年-2029年：純度98.5%-99%、純度≧99%

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp